Company / Share Buybacks
Anika Therapeutics, Inc. Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$9.5M
FY2025
5-year range
$5.0M / $30.0M
FY2021-FY2025
Trend
-13.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $5M to $9M over the past 2 years.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of -20.6%.
Improved from $5M to $9M over the past 2 years.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -20.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -20.6%, indicating a declining trend.
- In FY2025, share buybacks decreased 13.1% year-over-year.
- Peak share buybacks was recorded in FY2021.
- Lowest share buybacks in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.5M | -13.1% |
| FY2024 | $10.9M | +118.3% |
| FY2023 | $5.0M | - |
| FY2022 | - | - |
| FY2021 | $30.0M | +0.0% |
| FY2020 | $30.0M | +0.0% |
| FY2019 | $30.0M | +20.0% |
| FY2018 | $25.0M | +0.0% |
| FY2017 | $25.0M | +0.0% |
| FY2016 | $25.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026